Catch up on stories from the past week (and beyond) at the Slashdot story archive

 



Forgot your password?
typodupeerror
×
Medicine

Some Tumors Are Responding to A New Cancer Therapy (bloomberg.com) 53

A new cancer therapy in an early-stage trial by the U.S. National Cancer Institute "continued to be safe and show durable responses against solid tumors for some patients," reports Bloomberg. "In a trial of 14 patients who received different doses, three patients' cancers have shrunk partially, according to a study presented Sunday... The researchers had presented initial positive data in November, and the updated study shows that the three partial responses were durable, with one cervical cancer patient's response continuing at 15 months." Kite Pharma Inc. licensed the therapy, and by the end of the year will file an "investigational new drug" application with the FDA to begin the next round of testing. The therapy involves genetically engineered T cells, targeted to the solid tumors using the MAGE-A3 protein as a unique marker expressed in up to 30 percent of cancers.
This discussion has been archived. No new comments can be posted.

Some Tumors Are Responding to A New Cancer Therapy

Comments Filter:
  • by Ubi_NL ( 313657 ) <joris.benschop@NOspam.gmail.com> on Sunday April 17, 2016 @01:55PM (#51927655) Journal

    This just takes the price for least informative summary ever. So a new cancer drug has effects. Ok great, every day we see these trials and most have at least some effect. Only in the last sentence is desribed why this particular trial is worth mentioning.

    • by umafuckit ( 2980809 ) on Sunday April 17, 2016 @04:00PM (#51928035)

      This just takes the price for least informative summary ever. So a new cancer drug has effects. Ok great, every day we see these trials and most have at least some effect. Only in the last sentence is desribed why this particular trial is worth mentioning.

      The summary says "The therapy involves genetically engineered T cells, targeted to the solid tumors using the MAGE-A3 protein as a unique marker expressed in up to 30 percent of cancers." Seems pretty informative to me.

      • by dgatwood ( 11270 )

        The summary says "The therapy involves genetically engineered T cells, targeted to the solid tumors using the MAGE-A3 protein as a unique marker expressed in up to 30 percent of cancers." Seems pretty informative to me.

        In journalism, they call that "burying the lede". That bit should have been in the very first sentence, or at the very latest, the second sentence. Instead, it is at the very end of the story, where it is almost guaranteed to get chopped off in the future by some well-meaning editor trying

      • by rs79 ( 71822 )

        Nah it's pretty mundane and only tells you about their stuff, how it does something complicated and patentable with something expressed by 30% of cancers. Big deal.

        In 2007, Potter, Burke et al found CYP1B1 in nearly 100% of cancers.

        Fitst they found Resveratrol ("red wine") killed cells with these markers (which turn the Resveratrol into potential which kills only that cell) but it wasn't strong enough to work on humans. Next they found the Salvestrol family of molecules.

        Have a look for yourself how well tha

      • by Ubi_NL ( 313657 )

        yes in the last sentence, this is what i mentioned.

    • My eye's glazed over at Bloomberg
  • Coming soon (Score:5, Insightful)

    by Dunbal ( 464142 ) * on Sunday April 17, 2016 @01:56PM (#51927661)
    For only $500,000 per dose.
    • For only $500,000 per dose.

      But only $20 in Canada.

    • by dgatwood ( 11270 )

      For only $500,000 per dose.

      For now.

      Historically, T-cell therapy has been specific to a single person, because it had to be constructed using that person's own T cells. However, some teams are working on custom T cells that are modified to avoid expressing the genes that would normally cause them to attack unknown cells, thus allowing generic, off-the-shelf T cells to be introduced into anyone. Assuming it is possible to do that with CD4 cells, and assuming the immune system doesn't immediately attack and

    • by maxm ( 20632 )

      If you think that a viable and functioning treatment will keep staying expensive then you have very little imagination. Immune therapy is a hot topic these days, and seem to be very suitable for automation. It actually seem to be best suited for automation. So my best guess is that prices will plummet if it becomes standard.

  • by thinkwaitfast ( 4150389 ) on Sunday April 17, 2016 @03:01PM (#51927859)
    It's not a tumor.
  • Obligatory xkcd (Score:5, Interesting)

    by GuB-42 ( 2483988 ) on Sunday April 17, 2016 @04:32PM (#51928139)

    Genetically modified T-cells to treat cancer, reminds me of this.
    https://xkcd.com/938/ [xkcd.com]

  • Immunotherapy [wikipedia.org] has been applied to another type of cancer, and the results look promising.

    For those that don't know, immunotherapy was a big breakthrough in cancer research in 2010. It's very expensive, as it has to be tailor made to the patient and the specific form of cancer. Many times it involves genetically modifying the patient's immune system to recognize the cancer cells as an infection.
  • There are many spectacularly successful cures for cancers that simply enable the body to reverse the process that started the tumor in the first place.

    My father-in-law had a 10cm lung tumour last year and in 23 days the tumor shrank 50% and was gone in 60 days. The "magic"? The juice of 1.5kg of carrots daily.

    Oncologists just laugh and shake their heads because their information network doesn't have room for anything outside the feeds from their petro-chemical overlords. Yes, I said it. They're just b

One person's error is another person's data.

Working...